Literature DB >> 10590501

Atrial fibrillation: defining potential curative ablation targets.

D G Benditt1, N Samniah, G J Fahy, K G Lurie, S Sakaguchi.   

Abstract

The concept that atrial fibrillation (or at least certain forms of the arrhythmia) may be amenable to reversal or amelioration by transcatheter ablation techniques has become increasingly accepted in recent years. As yet, however, the techniques being studied for ablation of atrial fibrillation address neither known critical anatomic elements nor well defined electrophysiologic markers. The approaches, although essentially empirical, are conceptually based on the 'multiple wavelet' or 'focal origin' hypotheses. To date, addressing 'focal origin' atrial fibrillation by transcatheter ablation has been the more encouraging. However, as technology evolves, both in terms of catheter design and possibly endocardial mapping techniques, approaches to wavelet or rotor mechanisms may become similarly effective. This communication examines concepts regarding the manner in which atrial fibrillation is initiated and maintained. The goals are to better understand the encouraging success of empirical ablation methods, and possibly derive insights which may help refine ablation targeting in the future.

Entities:  

Mesh:

Year:  2000        PMID: 10590501     DOI: 10.1023/a:1009807304917

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  14 in total

1.  A COMPUTER MODEL OF ATRIAL FIBRILLATION.

Authors:  G K MOE; W C RHEINBOLDT; J A ABILDSKOV
Journal:  Am Heart J       Date:  1964-02       Impact factor: 4.749

2.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge.

Authors:  G K MOE; J A ABILDSKOV
Journal:  Am Heart J       Date:  1959-07       Impact factor: 4.749

3.  The coherence spectrum. A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms.

Authors:  K M Ropella; A V Sahakian; J M Baerman; S Swiryn
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

4.  The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure.

Authors:  J L Cox; R B Schuessler; H J D'Agostino; C M Stone; B C Chang; M E Cain; P B Corr; J P Boineau
Journal:  J Thorac Cardiovasc Surg       Date:  1991-04       Impact factor: 5.209

5.  Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; L Gencel; V Pradeau; S Garrigues; S Chouairi; M Hocini; P Le Métayer; R Roudaut; J Clémenty
Journal:  J Cardiovasc Electrophysiol       Date:  1996-12

6.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; L Gencel; M Hocini; J Clémenty
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

7.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

8.  Five-year experience with the maze procedure for atrial fibrillation.

Authors:  J L Cox; J P Boineau; R B Schuessler; K M Kater; D G Lappas
Journal:  Ann Thorac Surg       Date:  1993-10       Impact factor: 4.330

9.  Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases.

Authors:  M Haïssaguerre; F I Marcus; B Fischer; J Clémenty
Journal:  J Cardiovasc Electrophysiol       Date:  1994-09

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  1 in total

1.  Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease.

Authors:  Barış Akdemir; David G Benditt
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.